Attorney General Formally Moves To Reschedule Marijuana, But DEA Signals Resistance Despite DOJ Legal Review - Marijuana Moment

Contributing sentiments towards policy:

62% : The public comment period that will soon open is expected to receive historic attention given widespread public support for broad legalization and competing perspectives about the appropriateness of a Schedule III designation.
49% : Also, it explains that cannabis would continue to be subject to the Federal Food, Drug, and Cosmetic Act (FDCA), which means cannabis products would require Food and Drug Administration (FDA) approval in order to be lawfully introduced into interstate commerce.
42% : "Finally, it concluded that neither the United Nations (UN) Single Convention treaty nor the CSA require DEA to keep marijuana in either Schedule I or Schedule II, as the agency has asserted in previous rejections of rescheduling petitions such as a 2016 denial.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.